06 April 2021 | PlantForm announced it has reached a collaborative research and development agreement with...

Home / News / Pearce IP Blog
06 April 2021 | PlantForm announced it has reached a collaborative research and development agreement with...
29 March 2021 | Samsung Bioepis announced on 29 March 2021 that it has launched Hadlima®, its 50mg/mL biosimilar...
24 March 2021 | EirGenix announced that its Ph III clinical trial of EG12014 (proposed trastuzumab biosimilar) has met...
15 March 2021 | Alvotech announced it has completed a second round of its US$100 million private placement. In the...
04 Mar 21 | US | The US Senate unanimously passed the Ensuring Innovation Act and the Advancing Education on...
01 Mar 2021 | EU | Biocon and Viatris announced that the CHMP has adopted a positive opinion recommending the marking...
23 Feb 2021 | In its Q4 2020 investor presentation, Fresenius Kabi announced it will launch its biosimilar adalimumab...
13 Feb 2021 | Saudi Arabia's Tabuk Pharmaceuticals announced it has reached an exclusive licensing and distribution...
As discussed in Part 1 of this blog series, TGA has invited submissions by 23 March 2021 on its consultation paper...
In honour of UN International Day of Women and Girls in Science Last Thursday was the International Day of Women and...
04 Feb 2021 | Roche reported a huge erosion of its year on year CER growth in key areas, attributing this decline to...
TGA has invited submissions on its consultation paper released last Thursday designed to facilitate indication...
29 Jan 21 | EU | The CHMP recommended 13 medicines for approval. Among the recommendations were two bevacizumab...
25 Jan 21 | Samsung Bioepis announced the opening of its new headquarters in Incheon. The building was complete in...
18 Jan 21 | Prestige Biopharma announced it is set for an IPO in early February 2021. The IPO is expected to be worth...
07 Jan 21 | ADQ announced it will acquire Pharmax Pharmaceuticals, as well as investing in a minority stake in Biocon...